Lina Khan, FTC chair (Michael Brochstein/Sipa USA/Sipa via AP Images)
Improper Orange Book listings harm competition, FTC says in amicus brief to antitrust suit
The FTC on Monday filed an amicus brief in Mylan Pharmaceuticals’ antitrust lawsuit alleging that Sanofi abused the FDA’s Orange Book to delay and block …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.